48 related articles for article (PubMed ID: 11912160)
21. p62 binding to protein kinase C ζ regulates tumor necrosis factor α-induced apoptotic pathway in endothelial cells.
Kim GY; Nigro P; Fujiwara K; Abe J; Berk BC
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2974-80. PubMed ID: 23023376
[TBL] [Abstract][Full Text] [Related]
22. Discovery and optimization of 1,3,5-trisubstituted pyrazolines as potent and highly selective allosteric inhibitors of protein kinase C-ζ.
Abdel-Halim M; Diesel B; Kiemer AK; Abadi AH; Hartmann RW; Engel M
J Med Chem; 2014 Aug; 57(15):6513-30. PubMed ID: 25058929
[TBL] [Abstract][Full Text] [Related]
23. PKC zeta mTOR pathway: a new target for rituximab therapy in follicular lymphoma.
Leseux L; Laurent G; Laurent C; Rigo M; Blanc A; Olive D; Bezombes C
Blood; 2008 Jan; 111(1):285-91. PubMed ID: 17855629
[TBL] [Abstract][Full Text] [Related]
24. Structure-based lead discovery for protein kinase C zeta inhibitor design by exploiting kinase-inhibitor complex crystal structure data and potential therapeutics for preterm labour.
Shao QC; Zhang CJ; Li J
Arch Pharm Res; 2014 Oct; ():. PubMed ID: 25311663
[TBL] [Abstract][Full Text] [Related]
25. 14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression.
Breedy S; Ratnayake WS; Lajmi L; Hill R; Acevedo-Duncan M
Front Oncol; 2023; 13():1051516. PubMed ID: 36776326
[TBL] [Abstract][Full Text] [Related]
26. Targeting Drug Chemo-Resistance in Cancer Using Natural Products.
Talib WH; Alsayed AR; Barakat M; Abu-Taha MI; Mahmod AI
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680470
[TBL] [Abstract][Full Text] [Related]
27. Mitochondria: Insights into Crucial Features to Overcome Cancer Chemoresistance.
Genovese I; Carinci M; Modesti L; Aguiari G; Pinton P; Giorgi C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946271
[TBL] [Abstract][Full Text] [Related]
28. Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion.
Ratnayake WS; Apostolatos CA; Breedy S; Dennison CL; Hill R; Acevedo-Duncan M
Cell Adh Migr; 2021 Dec; 15(1):37-57. PubMed ID: 33525953
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C and cancer: what we know and what we do not.
Garg R; Benedetti LG; Abera MB; Wang H; Abba M; Kazanietz MG
Oncogene; 2014 Nov; 33(45):5225-37. PubMed ID: 24336328
[TBL] [Abstract][Full Text] [Related]
30. The selective inhibition of nuclear PKCζ restores the effectiveness of chemotherapeutic agents in chemoresistant cells.
Rimessi A; Zecchini E; Siviero R; Giorgi C; Leo S; Rizzuto R; Pinton P
Cell Cycle; 2012 Mar; 11(5):1040-8. PubMed ID: 22333579
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase C isoforms: Multi-functional regulators of cell life and death.
Reyland ME
Front Biosci (Landmark Ed); 2009 Jan; 14(6):2386-99. PubMed ID: 19273207
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo evaluation of the influence of type III NaPi co-transporter activity during apoptosis on 99mTc-(V)DMSA uptake in the human leukaemic cell line U937.
Denoyer D; Perek N; Jeune NL; Frere D; Sabido O; Clotagatide A; Dubois F
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1421-7. PubMed ID: 15205924
[TBL] [Abstract][Full Text] [Related]
33. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
Shi RX; Ong CN; Shen HM
Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
[TBL] [Abstract][Full Text] [Related]
35. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
37. Chemoresistance and Cancer-Related Inflammation: Two Hallmarks of Cancer Connected by an Atypical Link, PKCζ.
Rimessi A; Patergnani S; Ioannidi E; Pinton P
Front Oncol; 2013 Sep; 3():232. PubMed ID: 24062985
[TBL] [Abstract][Full Text] [Related]
38. Atypical protein kinase C zeta as a target for chemosensitization of tumor cells.
Filomenko R; Poirson-Bichat F; Billerey C; Belon JP; Garrido C; Solary E; Bettaieb A
Cancer Res; 2002 Mar; 62(6):1815-21. PubMed ID: 11912160
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
